Article abstract


Nature Immunology 9, 176 - 185 (2008)
Published online: 13 January 2008 | Corrected online: 19 March 2008 | doi:10.1038/ni1554



There is a Corrigendum (May 2008) associated with this Article.

CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator

Guifang Cai1, Anukanth Anumanthan1, Julia A Brown1, Edward A Greenfield1, Baogong Zhu1 & Gordon J Freeman1


CD160, a glycosylphosphatidylinositol-anchored member of the immunoglobulin superfamily, is expressed on both cytolytic lymphocytes and some unstimulated CD4+ T cells. Here we show that CD160 expression was increased after activation of human CD4+ T cells and that crosslinking CD160 with monoclonal antibody strongly inhibited CD3- and CD28-mediated activation. We found that herpesvirus entry mediator (HVEM) was a ligand of CD160 that acted as a 'bidirectional switch' for T cell activation, producing a positive or negative outcome depending on the engagement of HVEM by CD160 and known HVEM ligands such as B and T lymphocyte attenuator (BTLA) and the T lymphocyte receptor LIGHT. Inhibition of CD4+ T cell activation by HVEM-transfected cells was dependent on CD160 and BTLA; when the cysteine-rich domain 1 of HVEM was deleted, this inhibition was lost, resulting in strong T cell activation. CD160 thus serves as a negative regulator of CD4+ T cell activation through its interaction with HVEM.

Top
  1. Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.

Correspondence to: Gordon J Freeman1 e-mail: gordon_freeman@dfci.harvard.edu

* In the version of this article initially published, the citation for Supplementary Figure 2c on page 179 and the citation for Supplementary Figure 3a on page 180 are incorrect. These should be "Supplementary Fig. 2a–c" and "Supplementary Fig. 3," respectively. The errors have been corrected in the HTML and PDF versions of the article.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

CD160 and BTLA: LIGHTs out for CD4 + T cells

Nature Immunology News and Views (01 Feb 2008)


Extra navigation

Subscribe to Nature Immunology

Subscribe

Open Innovation Challenges

naturejobs

natureproducts


ADVERTISEMENT